Omicron, the less active vaccinated antibodies against the variant
The anti-Covid vaccines could lose part of their effectiveness in the face of the Omicron variant: this is suggested by five papers just published in
The anti-Covid vaccines could lose part of their effectiveness in the face of the Omicron variant: this is suggested by five papers just published in
There is a new way to hinder the entry into cells of the SarsCoV2 virus and its variants. it is different from both vaccines and
(ANSA) – ROME, NOVEMBER 10 – The first new generation monoclonal antibody capable of protecting all newborns from respiratory syncytial virus, through a prophylaxis capable
(ANSA) – ROME, 02 NOV – Monoclonal antibodies are effective in protecting elderly and diabetic macaque monkeys from the damage caused by Covid-19 at the